Home » Search
Search Results
2,997 results for 'physician'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Pedal pubs are latest hit in a beer-loving city
Booze and bicycling—in the most unconventional sense—is the thrust behind The Handle Bar, a local startup operated by Steve Lindsay and his brother Brian.
Healthx using IT to connect insurers to their customers
Health insurance has long been a business-to-business endeavor between insurers, employers, hospitals and doctors. Patients received benefits, but they weren’t really customers. That’s all about to change.
2013 Healthiest Employers: Endress+Hauser Inc.
5,000+ EMPLOYEES Friendly competition with coworkers can be a big motivator when it comes to workplace wellness. When the coworker is your boss, and an iron man triathlete at that, competing—and winning—is that much sweeter. At Endress+Hauser, a Greenwood-based supplier of industrial measurement and automation equipment, a favorite competition is the Endress 500. In the […]
2013 Healthiest Employers: Draper Inc.
500-1,499 EMPLOYEES Draper Inc. brings wellness on-site with amenities, fitness challenges One of Draper’s fitness challenges ended with a bike giveaway. (Photo provided) Draper Inc. is on the edge of Spiceland, a small town about 40 miles east of Indianapolis. Which is a nice way of saying that the company is located between two cornfields. […]
2013 Healthiest Employers: Goodwill Industries of Central Indiana Inc.
1,500-4,999 EMPLOYEES Goodwill helps employees scale steep learning curve on road to wellness Goodwill employees participate in the Wear Blue event, the kick-off for Men’s Health Month. (Photo provided) This is the second season for the company’s on-site gardenGoodwill Industries of Central Indiana faces some unique challenges in making wellness a priority for its more […]
Swapping Obamacare for a single-payer system?
How would a single-payer national health insurance program change the finances for employers, workers, doctors and hospitals?
Doctor charged with overprescribing painkillers
Dr. Segun Rasaki, 49, prescribed drugs like hydrocodone and methadone to people who didn’t need them, and submitted fraudulent insurance claims such as duplicate billings, according to court documents.
Company news
Dr. Segun Rasaki, an Indianapolis physician, has been charged with 24 felonies for allegedly prescribing controlled substances such as hydrocone, methadone and oxycodone without a legitimate medical purpose, according to charges announced Monday by the Marion County Prosecutor’s Office. Rasaki, who was being held Monday in the Marion County Jail, describes himself as an "independent hospital and health care professional" on his LinkedIn page. In an unrelated case, Rasaki was convicted in 2012 of sexually abusing patients. The state’s medical licensing board revoked his medical license in the same year. According to an investigation by state and federal investigators, Rasaki prescribed painkillers illegally to 11 patients as well as to one undercover agent of the U.S. Drug Enforcement Agency. He also allegedly filed more than $5,000 in fraudulent claims against health insurer Anthem Blue Cross and Blue Shield for “ghost” office visits and unneeded medical services.
Eli Lilly and Co. stock jumped 5.5 percent Thursday after the Indianapolis-based drugmaker announced clinical trial results showing its experimental lung cancer medicine necitumumab increased patients' overall survival compared with those on chemotherapy alone. According to Bloomberg News, the drug was tested in nearly 1,100 patients with non-small-cell lung cancer with tumor types known as squamous. “This is a clear upside surprise,” Mark Schoenebaum, an analyst with ISI Group LLC, said in a note to clients. Analysts had “basically zero” expectations for necitumumab, Schoenebaum said in his note. The drug failed in a prior non-squamous lung cancer trial, he said. Lilly expects to publish results of the trial and submit the drug to regulators next year.
Public broadcasting station WFYI-FM 90.1 aims to expand distribution of its locally produced “Sound Medicine” show to at least 30 radio stations in large and medium-size markets in the next two years. The 12-year-old show already airs on 16 out-of-state stations as far away as Alaska. WFYI has lassoed two years’ funding to “build a sustainable national brand” for the show, which the station produces through a partnership with Indiana University School of Medicine. As for how much money was recently committed, and by whom, station executives declined to say. In the past, much of the funding has come from Indiana University Health Physicians and from IUPUI, which often are mentioned during the program. The new funds are being used to add an executive producer tasked with improving distribution and content of the program, which is distributed without charge to stations interested in running it. "Trying to negotiate a license fee at this point is a barrier to carriage," said Alan Cloe, executive vice president of content services at WFYI. "Sound Medicine," whose primary host is former WRTV-TV Channel 6 anchor Barbara Lewis, covers everything from new medical treatments to dispelling common medical myths.
Ivy Tech Community College is cutting hours for its part-time professors in preparation for implementing the Obamacare overhaul of health insurance. The law requires employers to provide health insurance to part-time employees who work 30 hours a week or more, and the Obama administration has said it will start enforcing that provision in 2015. Colleges and the Obama administration are also still trying to figure out how to convert colleges’ system of counting credit hours into a reliable system of hours worked. Ivy Tech President Tom Snyder said the college system reduced most of its part-time faculty's credit hours to nine to provide leeway for unresolved issues such as how preparation time is counted. About 60 percent of Ivy Tech professors work part time. Snyder says college officials would prefer the figure be 50 percent, but he says that would require an additional $50 million in state funding.
People
A.J. Baucum, a neuroscience researcher, has joined the department of biology at the IUPUI School of Science. He worked for the past two years as a research instructor at Vanderbilt University. Baucum earned his doctorate in pharmacology and toxicology at the University of Utah. He also has an undergraduate degree in biology from Loyola Marymount in Los Angeles.
Dr. Michael Large, a urologist, has joined the Urology of Indiana physician practice. He earned his bachelor’s in biology from Harvard University and his medical degree from the Indiana University School of Medicine.
Dr. Brent Suozzi, a urologic and gynecologic surgeon, has joined the Urology of Indiana physician practice. He earned his bachelor’s in biology from Indiana University and his medical degree at the IU School of Medicine.
$11M Irvington apartment project entering second phase
Irvington Lofts, a 50-unit affordable housing project, is slated to open in the fall, as construction begins on a nearly 6,000-square-foot adjacent medical office that will be occupied by Franciscan St. Francis Health.
Indiana board considers 1-year delay of patient tests
Indiana's Medical Licensing Board is considering delaying for one year a proposed new rule that would require physicians to conduct annual toxicology tests on some patients as part of a larger state effort to crack down on prescription drug abuse.
SEC accuses Indy cancer firm of being a sham
The SEC says the CEO of locally based biomedical firm Xytos Inc. has committed securities fraud
since 2010 by repeatedly publishing false information to investors about the company. Timothy Cook denies the accusations.Patients get what they pay for
Patients, in spite of what it may feel like, pay only a tiny fraction of the total health care bill directly from their own pockets. It’s no wonder then that prices and good service are hard to find.
Which Indy hospitals do it right the first time?
Medicare data show some county-owned hospitals around Indianapolis scored better than big-name hospitals like IU Health and Community.
China bribery probe leading to tough drug market, CEO says
Drugmakers under investigation for bribery have stopped promoting products in China, and physicians in some hospitals no longer want to meet sales representatives. Eli Lilly is among the drugmakers in China facing allegations.
OurHealth readies citywide network of employer clinics
In a bid to make employer-sponsored health clinics available to companies of all sizes, Indianapolis-based OurHealth will open a network of seven offices around Indianapolis next year.
Ouch! Indy hospitals charging employers three times more than Medicare
A new study found that Indianapolis-area hospitals are charging patients insured by their employers 264 percent more for outpatient services than the federal Medicare program pays for the exact same services at the same hospitals.
Company news
Indianapolis-based Harlan Laboratories may violate loan covenants in the next three to six months, and its ability to refinance a $280 million loan that matures in July 2014 is “highly questionable,” according to a report by Moody’s Investors Service. It’s unclear if the privately held company has an escape plan brewing. Harlan Laboratories employs about 330 people in the area and has annual sales of $326 million. The company appeared on the verge of pulling off a $305 million refinancing in February, but the deal fell apart and was shelved in April, according to Standard & Poor’s Ratings Corp. The ratings agencies say the company is not performing well enough to attract lenders. And even if it could engineer a refinancing, it likely would struggle to make the required payments. By Moody’s tally, Harlan’s “adjusted debt” is a whopping 7-1/2 times its so-called EBITDA (earnings before interest, taxes, depreciation and amortization).
Indianapolis-area hospitals are billing patients insured by their employers 264 percent more for outpatient services than what the federal Medicare program would pay for the same services for the same patients in the same facilities. That’s what researchers at the Washington, D.C.-based Center for Studying Health System Change found when they analyzed claims data for 590,000 patients, all below the age of 65, who were covered in 2011 by the union-negotiated health plans at automakers General Motors, Ford and Chrysler. The study was paid for by an organization that is funded by the automakers, the UAW and the International Union. The study compared the claims from 13 metro areas against one anther, all of them in the Midwest. Indianapolis had the highest hospital outpatient prices among all cities and the second-highest inpatient prices, behind only Kansas City. Interestingly, Kokomo had the third-highest inpatient prices and the second-highest outpatient prices. Physician prices in Indianapolis were in the middle of the pack, about 10 percent to 20 percent higher than Medicare prices. The authors of the study say hospitals’ market power, which has increased in recent years due to consolidation among hospitals and doctors, is the most likely explanation for the higher prices.
New Jersey-based Covance Inc. has formed a collaboration with the Indiana Clinical and Translational Sciences Institute to conduct early-stage clinical trials for biotechnology and pharmaceutical companies. The Indiana CTSI, which was formed by partnership of Indiana, Purdue and Notre Dame universities, will provide access to a 13,606-square-foot, 24-patient facility at IU Health University Hospital in Indianapolis. The institute also could, if needed, expand operations into a recently renovated 33,078-square-foot, 50-patient facility in the same building. This space reopens to clinical research for the first time in six years due to the efforts of the Indiana CTSI. The alliance between Covance and the Indiana CTSI was facilitated by BioCrossroads, an Indianapolis-based life sciences business development group. Covance already conducts Phase 1 clinical trials at an 80-bed facility in Evansville. But there has been a paucity of Phase 1 clinical trial work in Indianapolis since locally based drugmaker Eli Lilly and Co. shut down its clinic at the IU School of Medicine in 2007.